Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A new lawsuit accuses the imprisoned hedge funder of blocking generic rivals of an AIDS-related drug.
But that doesn’t mean the Affordable Care Act is safe. Here’s what’s up next.
Health officials with Goshen Hospital in Indiana called the risk of infection “extremely low.”
The suit alleges “cruel and unusual punishment” by state prison officials.
The lawsuit seeks to force prisons to step up to the plate with hep C therapy and follows others filed in numerous states.
Three distributors and a drugmaker may avert the first federal trial over their role in the U.S. opioid crisis.
Massive legal payouts are likely coming—but it’s still unclear where they will go.
Abu-Jamal spent years fighting for access to hepatitis C treatment in prison.
This is one of several lawsuits filed by advocates on behalf of inmates with the liver virus in U.S. prisons.
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
Plaintiffs in Georgia, Michigan, Kansas and Missouri say new rules will leave less populous areas with fewer organs than urban regions.
The right was secured via a class-action lawsuit settlement.
Three lawsuits allege prison officials denied them treatment for more than a year, despite serious illness.
Nearly 3,800 patients at the New Jersey surgery center may have been exposed, though the risk of infection is low.
The pharmacy chains were added to an existing lawsuit against opioid distributors and manufacturers.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.